PlainPatent
USPTO 2015–2025 USPTO PatentsView US Corporation

Visby Medical, Inc.

USPTO PatentsView assignee record - 20 granted patents across 7 technology areas, active 2020–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).

Explore the portfolio See the ranking
20
Total patents granted
7
CPC technology areas
17.3
Avg claims per patent
-
5-year filing velocity

The verdict

Visby holds 20 US patents across 7 technology areas, rank #15,042 of 50,000 tracked assignees.

#15,042
of 50,000 US assignees by volume
Top 47%
by Innovation Score (36.0/100)
17.3
avg claims per patent

Portfolio overview

Visby Medical, Inc. has been granted 20 US utility patents between 2020 and 2025, placing Visby Medical, Inc. at rank #15,042 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.3 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Visby Medical, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 36.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 20 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Visby Medical, Inc.'s 17.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Visby Medical, Inc. against peers pursuing similar technology classes.

How does Visby compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Visby holds 20 patents, placing it at rank #15,042 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Visby's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

1234567 20202021202220242025 5
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Visby Medical, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 2 10.0%
2021 6 30.0%
2022 3 15.0%
2024 4 20.0%
2025 5 25.0%

Which technologies does Visby Medical, Inc. patent most?

Top 7 of 7 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard

Where it ranks

Overall rank by patents

#15,042

Across all tracked assignees

Innovation Score

36.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Visby Medical, Inc. hold?
Visby Medical, Inc. holds 20 US granted patents filed between 2020 and 2025, spanning 7 technology areas.
What is Visby Medical, Inc.'s Innovation Score?
Visby Medical, Inc. has an Innovation Score of 36.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Visby Medical, Inc. focus on?
Visby Medical, Inc.'s top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 15 patents. The company has filed patents in 7 CPC subclasses total.
Is Visby Medical, Inc.'s patent filing rate increasing or decreasing?
Insufficient historical data is available to calculate a velocity trend for Visby Medical, Inc..
What does claim depth mean for Visby Medical, Inc.'s patents?
Visby Medical, Inc.'s patents average 17.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the Visby Medical, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

How to use this portfolio

Visby's 20 grants land it in the top 47% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Visby ranks #15,042 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B01L - see who else leads that technology area. B01L leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

B01L technology

Visby Medical, Inc.'s primary CPC class, all holders and yearly trends
Top 50 patent holders

See where Visby Medical, Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov